Targeting CD40L: a promising therapeutic approach.
Daoussis
Dimitris
D
Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece.
Andonopoulos
Andrew P
AP
Liossis
Stamatis-Nick C
SN
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology*; D023201:CD40 Ligand / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D023201:CD40 Ligand